References

Key articles

Report of WHO/UNICEF/UNU consultation on indicators and strategies for iron deficiency and anemia programmes. In: WHO/UNICEF/UNU consultation. Geneva, Switzerland: WHO; 1994.

Brown RG. Anemia. In: Taylor RB, ed. Family medicine: principles and practice. 4th ed. New York, NY: Springer-Verlag; 1994:997-1005.

Zuckerman KS. Approach to the anemias. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007: chapter 162.

Glader BE. Hemolytic anemia in children. Clin Lab Med. 1999 Mar;19(1):87-111, vi.

Ginder GD. Microcytic and hypochromic anemias. In: Goldman L, Ausiello DA, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007: chapter 163.

Killick SB, Bown N, Cavenagh J, et al; British Society for Standards in Haematology. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016 Jan;172(2):187-207.

Reference articles

1.  Report of WHO/UNICEF/UNU consultation on indicators and strategies for iron deficiency and anemia programmes. In: WHO/UNICEF/UNU consultation. Geneva, Switzerland: WHO; 1994.

2.  Lee GR, Foerster J, Lukens J. Wintrobe's clinical hematology. 10th ed. Baltimore, MD: Lippincott, Williams & Wilkins; 1999.

3.  Beutler E, Lichtman MA, Coller BS, et al. Williams hematology. 6th ed. New York, NY: McGraw-Hill; 2000.

4.  Brown RG. Anemia. In: Taylor RB, ed. Family medicine: principles and practice. 4th ed. New York, NY: Springer-Verlag; 1994:997-1005.

5.  Thein M, Ershler WB, Artz AS, et al. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine (Baltimore). 2009;88:107-14.

6.  Zuckerman KS. Approach to the anemias. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007: chapter 162.

7.  Glader BE. Hemolytic anemia in children. Clin Lab Med. 1999 Mar;19(1):87-111, vi.

8.  Ginder GD. Microcytic and hypochromic anemias. In: Goldman L, Ausiello DA, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007: chapter 163.

9.  Brill JR, Baumgardner DJ. Normocytic anemia. Am Fam Physician. 2000 Nov 15;62(10):2255-64.

10.  Davenport J. Macrocytic anemia. Am Fam Physician. 1996 Jan;53(1):155-62.

11.  Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007 Dec;13(12):1545-53.

12.  Madore F, White CT, Foley RN, et al; Canadian Society of Nephrology. Clinical practice guidelines for assessment and management of iron deficiency. Kidney Int Suppl. 2008 Aug;(110):S7-S11.

13.  Conrad ME, Umbreit JN. Iron absorption and transport - an update. Am J Hematol. 2000 Aug;64(4):287-98.

14.  Centers for Disease Control and Prevention (CDC). Iron deficiency: United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2002 Oct 11;51(40):897-9.

15.  den Elzen WP, van der Weele GM, Gussekloo J, et al. Subnormal vitamin B12 concentrations and anaemia in older people: a systematic review. BMC Geriatrics. 2010 Jun 23;10:42.

16.  Fernando OV, Grimsley EW. Prevalence of folate deficiency and macrocytosis in patients with and without alcohol-related illness. South Med J. 1998 Aug;91(8):721-5.

17.  Ma X, Does M, Raza A, et al. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007 Apr 15;109(8):1536-42.

18.  Killick SB, Bown N, Cavenagh J, et al; British Society for Standards in Haematology. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016 Jan;172(2):187-207.

19.  Young NS. Pathophysiologic mechanisms in acquired aplastic anemia. Hematology Am Soc Hematol Educ Program. 2006;72-7.

20.  Cheungpasitporn W, Thongprayoon C, Chiasakul T, et al. Renin-angiotensin system inhibitors linked to anemia: a systematic review and meta-analysis. QJM. 2015 Nov;108(11):879-84.

21.  Zarychanski R, Houston DS. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ. 2008 Aug 12;179(4):333-7. [Erratum in: CMAJ. 2008 Aug 26;179(5):449.]

22.  Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-42.

23.  White CT, Barrett BJ, Madore F, et al; Canadian Society of Nephrology. Clinical practice guidelines for evaluation of anemia. Kidney Int Suppl. 2008 Aug;(110):S4-6.

24.  National Institute for Health and Care Excellence. Chronic kidney disease: managing anaemia. June 2015 [internet publication].

25.  Hashimoto C. Autoimmune hemolytic anemia. Clin Rev Allergy Immunol. 1998 Fall;16(3):285-95.

26.  Bledsoe GH. Malaria primer for clinicians in the United States. South Med J. 2005 Dec;98(12):1197-204.

27.  Ryan K, Bain BJ, Worthington D, et al; British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010 Apr;149(1):35-49.

28.  Langlois S, Ford JC, Chitayat D, et al; CCMG Prenatal Diagnosis Committee; SOGC Genetic Committee. Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can. 2008 Oct;30(10):950-9.

29.  Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003 Mar;17(1):43-53.

30.  Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008 Jan 1;111(1):16-24.

31.  Martinez J. Microangiopathic hemolytic anemia. In: Beutler E, Lichtman MA, Coller BS, et al., eds. Williams hematology. 5th ed. New York, NY: McGraw-Hill; 1995:669.

32.  Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol. 2004 Mar;124(5):567-76.

33.  Levi M. The coagulant response in sepsis. Clin Chest Med. 2008 Dec;29(4):627-42, viii.

34.  Chiao EY, Engels EA, Kramer JR, et al. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med. 2009 Feb 23;169(4):357-63.

35.  Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994 Feb;89(2):635-41.

36.  American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol. 2008 Jul;112(1):201-7.

37.  Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000;900:125-36.

38.  Rukuni R, Knight M, Murphy MF, et al. Screening for iron deficiency and iron deficiency anaemia in pregnancy: a structured review and gap analysis against UK national screening criteria. BMC Pregnancy Childbirth. 2015 Oct 20;15:269.

39.  Smith JW, Gamelli RL, Shankar R. Hematologic, hematopoietic and acute phase responses. In: Herndon DN, ed. Total burn care. Philadelphia, PA: Saunders-Elsevier; 2007:325-42.

40.  Koch CG, Li L, Sun Z, et al. Hospital-acquired anemia: prevalence, outcomes, and healthcare implications. J Hosp Med. 2013 Sep;8(9):506-12.

41.  Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999 Feb 11;340(6):409-17.

42.  Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016 Nov 15;316(19):2025-35.

43.  Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013 Feb 20;309(7):678-88. [Erratum in: JAMA. 2013 Mar 27;309(12):1229.]

44.  European Medicines Agency. Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients. June 2018 [internet publication].

45.  European Medicines Agency. Hydroxyethyl-starch solutions for infusion to be suspended - CMDh endorses PRAC recommendation. January 2018 [internet publication].

46.  Napolitano LM, Cohen MJ, Cotton BA, et al. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013 Jun;74(6):1575-86.

47.  Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016 Apr 12;20:100.

48.  Ker K, Roberts I, Shakur H, et al. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2015 May 9;(5):CD004896.

49.  Gayet-Ageron A, Prieto-Merino D, Ker K, et al; Antifibrinolytic Trials Collaboration. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018 Jan 13;391(10116):125-32.

50.  Karnad AB, Krozser-Hamati A. Pernicious anemia. Early identification to prevent permanent sequelae. Postgrad Med. 1992 Feb 1;91(2):231-4, 237.

51.  Samarasinghe S, Veys P, Vora A, et al. Paediatric amendment to adult BSH Guidelines for aplastic anaemia. Br J Haematol. 2018 Jan;180(2):201-5.

52.  Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010 Jan 19;152(2):101-13.

53.  Palamidessi N, Sinert R, Falzon L, et al. Nasogastric aspiration and lavage in emergency department patients with hematochezia or melena without hematemesis. Acad Emerg Med. 2010 Feb;17(2):126-32.

54.  Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2015 Oct;47(10):a1-46.

55.  Siminoff LA, Rogers HL, Harris-Haywood S. Missed opportunities for the diagnosis of colorectal cancer. Biomed Res Int. 2015;2015:285096.

56.  Dosh SA. Serum ferritin vs transferrin receptor-ferritin index. Arch Intern Med. 2002 Aug 12-26;162(15):1782.

57.  Public Health England. Test and treat for Helicobacter pylori (HP) in dyspepsia. July 2017 [internet publication].

58.  Finch CA, Bellotti V, Stray S, et al. Plasma ferritin determination as a diagnostic tool. West J Med. 1986 Nov;145(5):657-63.

59.  Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973 Apr 21;1(7808):882.

60.  Hoffmann JJ, Urrechaga E, Aguirre U. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis. Clin Chem Lab Med. 2015 Nov;53(12):1883-94.

61.  Rodgers GM 3rd, Becker PS, Bennett CL, et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2008 Jul;6(6):536-64.

62.  Collins AB, Pawlak R. Prevalence of vitamin B-12 deficiency among patients with thyroid dysfunction. Asia Pac J Clin Nutr. 2016;25(2):221-6.

Use of this content is subject to our disclaimer